Published in
Taylor and Francis Group, Journal of Dermatological Treatment, 3(33), p. 1718-1726, 2021
DOI: 10.1080/09546634.2021.1902925
Links
Tools
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study
Journal article published in 2021 by
Bardur Sigurgeirsson 
,
Knut Schäkel,
Chih-Ho Hong ,
Isaak Effendy ,
Waldemar Placek,
Phoebe Rich,
Deborah Keefe,
Gerard Bruin,
Pascal Charef,
Rong Fu,
Isabelle Hampele,
Manmath Patekar
,
Knut Schäkel,
Chih-Ho Hong ,
Isaak Effendy ,
Waldemar Placek,
Phoebe Rich,
Deborah Keefe,
Gerard Bruin,
Pascal Charef,
Rong Fu,
Isabelle Hampele,
Manmath Patekar
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 